Abstract: There is disclosed computer-implemented system and method of providing a wireless access point (WAP), including dividing the WAP into at least two virtual networks, wherein a first virtual network is for devices that authenticate using a first authentication protocol and a second virtual network is for devices that authenticate using a second authentication protocol, wherein the second authentication protocol is more secure than the first authentication protocol; and onboarding devices to the WAP, and assigning the devices to the at least two virtual networks according to the authentication protocols they use to authenticate to the WAP.

Abstract: A system and method for rule selection may include using one or more processors in a computer server, for a set of rules, each rule having one or more rule criteria, determining for each rule if the result of an interaction between interaction metadata and the one or more rule criteria includes one or more criteria. For each rule where the intersection includes one or more criteria, a complement result may be calculated between the result of the intersection and the rule criteria; and based on the complement result, wherein if the complement result is null, the rule may be selected.

Abstract: The present invention relates to topical pharmaceutical emulsion compositions comprising a therapeutically effective amount of 3,5-Dihydroxy-4-isopropyl-trans-stilbene or a pharmaceutically acceptable salt thereof, an oil phase, a water phase, a surfactant, and an antioxidant, and wherein the emulsion composition is homogeneous and/or the active is solubilized in the oil phase. The invention also relates to methods of treating a dermatological condition or disorder in a patient by administering the present compositions to the skin of the patient.

Abstract: Described are examples for receiving, by a network node, a request message from a user equipment (UE) to establish or modify a protocol data unit (PDU) session for the UE, and transmitting, by the network node, to the UE, and based on the request, a command message to establish or modify the PDU session for the UE, wherein the command message includes multiple traffic flow template (TFT) information elements per bearer.

Abstract: A system and method for rule selection may include using one or more processors in a computer server, for a set of rules, each rule having one or more rule criteria, determining for each rule if the result of an interaction between interaction metadata and the one or more rule criteria includes one or more criteria. For each rule where the intersection includes one or more criteria, a complement result may be calculated between the result of the intersection and the rule criteria; and based on the complement result, wherein if the complement result is null, the rule may be selected.

Abstract: Systems, methods, and computer-readable media are disclosed for systems and methods for sending and receiving requests to delete and/or retrieve certain data. Example methods may include sending from an electronic device a request to delete and/or retrieve selected data from a server based on selected categories, receiving the request at the server, and determining data to delete and/or retrieve on the server based on the request from the electronic device, deleting and/or retrieving the data on the server, and/or sending the retrieved selected to the electronic device.

Abstract: The present invention relates to topical pharmaceutical emulsion compositions comprising a therapeutically effective amount of 3,5-Dihydroxy-4-isopropyl-trans-stilbene or a pharmaceutically acceptable salt thereof, an oil phase, a water phase, a surfactant, and an antioxidant, and wherein the emulsion composition is homogeneous and/or the active is solubilized in the oil phase. The invention also relates to methods of treating a dermatological condition or disorder in a patient by administering the present compositions to the skin of the patient.

Abstract: The present invention relates to topical pharmaceutical emulsion compositions comprising a therapeutically effective amount of 3,5-Dihydroxy-4-isopropyl-trans-stilbene or a pharmaceutically acceptable salt thereof, an oil phase, a water phase, a surfactant, and an antioxidant, and wherein the emulsion composition is homogeneous and/or the active is solubilized in the oil phase. The invention also relates to methods of treating a dermatological condition or disorder in a patient by administering the present compositions to the skin of the patient.

Abstract: The present invention relates to topical pharmaceutical emulsion compositions comprising a therapeutically effective amount of 3,5-Dihydroxy-4-isopropyl-trans-stilbene or a pharmaceutically acceptable salt thereof, an oil phase, a water phase, a surfactant, and an antioxidant, and wherein the emulsion composition is homogeneous and/or the active is solubilized in the oil phase. The invention also relates to methods of treating a dermatological condition or disorder in a patient by administering the present compositions to the skin of the patient.

Abstract: The present invention relates to topical pharmaceutical emulsion compositions comprising a therapeutically effective amount of 3,5-Dihydroxy-4-isopropyl-trans-stilbene or a pharmaceutically acceptable salt thereof, an oil phase, a water phase, a surfactant, and an antioxidant, and wherein the emulsion composition is homogeneous and/or the active is solubilized in the oil phase. The invention also relates to methods of treating a dermatological condition or disorder in a patient by administering the present compositions to the skin of the patient.

Abstract: The present invention relates to topical pharmaceutical emulsion compositions comprising a therapeutically effective amount of 3,5-Dihydroxy-4-isopropyl-trans-stilbene or a pharmaceutically acceptable salt thereof, an oil phase, a water phase, a surfactant, and an antioxidant, and wherein the emulsion composition is homogeneous and/or the active is solubilized in the oil phase. The invention also relates to methods of treating a dermatological condition or disorder in a patient by administering the present compositions to the skin of the patient.

Abstract: The present invention relates to a method for in situ sensing of water stress in a plant by contacting a plant with a biosensor, where the biosensor comprises a material capable of giving a detectable response to changes in local water potential in the plant and detecting the detectable response thereby sensing water stress in the plant. The invention further relates to a method for determining water potential in a substance, a biosensor, a system for determining water potential in a substance, a method for determining water potential in a substance, a water potential measurement computing device, and a non-transitory computer readable medium having stored thereon instructions for determining water potential in a substance.

Abstract: Systems, methods, and media for laboratory testing services are disclosed. A request for an electronic form can be received from an electronic device. A customized electronic form can be sent to the electronic device. The electronic form may be customized based at least in part on a healthcare provider associated with the request. At least one laboratory test may be requested to be ordered for at least one patient associated with the healthcare provider. At least one predefined rule may be applied to the requested order to verify that the order is valid. At least one laboratory can be selected to perform the ordered laboratory tests. Specimen collection information may be sent to a collection facility and can be based at least in part on rules or preferences of a lab selected to perform a laboratory test. Customized test reports can be provided to a healthcare provider.

Abstract: Described are examples for receiving, by a network node, a request message from a user equipment (UE) to establish or modify a protocol data unit (PDU) session for the UE, and transmitting, by the network node, to the UE, and based on the request, a command message to establish or modify the PDU session for the UE, wherein the command message includes multiple traffic flow template (TFT) information elements per bearer.

Abstract: An ingress fabric endpoint coupled to a switch fabric within a network device reorders packet flows based on congestion status. In one example, the ingress fabric endpoint receives packet flows for switching across the switch fabric. The ingress fabric endpoint assigns each packet for each packet flow to a fast path or a slow path for packet switching. The ingress fabric endpoint processes, to generate a stream of cells for switching across the switch fabric, packets from the fast path and the slow path to maintain a first-in-first-out ordering of the packets within each packet flow. The ingress fabric endpoint switches a packet of a first packet flow after switching a packet of a second packet flow despite receiving the packet of the first packet flow before the packet of the second packet flow.

Abstract: The present invention relates to topical pharmaceutical emulsion compositions comprising a therapeutically effective amount of 3,5-Dihydroxy-4-isopropyl-trans-stilbene or a pharmaceutically acceptable salt thereof, an oil phase, a water phase, a surfactant, and an antioxidant, and wherein the emulsion composition is homogeneous and/or the active is solubilized in the oil phase. The invention also relates to methods of treating a dermatological condition or disorder in a patient by administering the present compositions to the skin of the patient.

Abstract: This disclosure describes, in part, techniques and systems for accurately and efficiently updating applications stored on client computing devices. In some instances, the systems and techniques receive an update from an application developer, but rather than send the update directly to a client computing device that operates the application, the systems and techniques determine one or more difference between the current update and an update previously sent to the client computing device and, thereafter, send a “diff file” indicative of these differences to the client computing device. The client computing device may then use the diff file and the previously received update to re-create the new update. Thus, the systems and techniques are able to update client computing devices while limiting the amount of data sent over a network to these devices.

Abstract: In some examples, active directory management and remediation may include obtaining data associated with active directories, and generating, based on the obtained data, a data model that includes a plurality of active directory concepts. A graph may be generated and include the active directory concepts as nodes and relationships between the nodes. The graph may be analyzed to identify user to group memberships. A membership score and a reasoning for the membership score may be determined for each identified user to group membership of the user to group memberships. The membership score and the reasoning for the membership score may be analyzed for each identified user to group membership. Further, based on the analysis of the membership score and the reasoning for the membership score, the at least one of the user to group memberships may be remediated.

Abstract: Embodiments described herein relate to topical pharmaceutical compositions comprising tapinarof, wherein the topical pharmaceutical composition is formulated as an aqueous gel, an anhydrous gel, an ointment, or a foam. Embodiments also relate to methods of treating a dermatological condition or disorder in a patient by administering the present compositions to the skin of the patient.

Abstract: Various implementations described herein are directed to device having a memory block and a sense amplifier coupled to the memory block. The device may include a bias generator that applies a bias signal to the sense amplifier for regulating read current to the sense amplifier for faster activation of the memory block.